Mergers and Acquisitions

Latest News

Image credit: Saint Luke's Health System
BJC HealthCare, Saint Luke’s Health System reach agreement on $10B merger

November 29th 2023

The two Missouri-based systems will form a combined system with 28 hospitals. The deal is expected to close by Jan. 1.

FTC sues to block $142M California hospital deal
FTC sues to block $142M California hospital deal

November 18th 2023

Novant Health strikes $2.4B deal to buy 3 hospitals from Tenet Healthcare
Novant Health strikes $2.4B deal to buy 3 hospitals from Tenet Healthcare

November 17th 2023

UCHealth poised to complete acquisition of struggling Parkview Health System
UCHealth poised to complete acquisition of struggling Parkview Health System

November 3rd 2023

Healthcare is ‘a team sport’ | Lessons for Leaders
Healthcare is ‘a team sport’ | Lessons for Leaders

October 31st 2023

Latest CME Events & Activities

2023 IASLC North America Conference on Lung Cancer Satellite Symposia

Register Now!

PER's Breast Cancer Symposia in San Antonio

Register Now!

Leukemia Therapy – A Look Into the Future

View More

2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition

Register Now!

Reflective Case-Based Oncology Collective: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care

View More

Burst CME™ - Part I – Overview of Pathophysiology, Diagnosis, and Management of HER3 Expressing Cancers

View More

Burst CME™ - Part III – Advent of HER3 Targeted Approaches and Rationale in Breast Cancer Care

View More

Burst CME™ - Part II – Advent of HER3 Targeted Approaches and Rationale in NSCLC Care

View More

Translating New Evidence into Treatment Algorithms from Frontline to R/R Multiple Myeloma: How the Experts Think & Treat

View More

Updates from the Annual Hematology Meeting: Matching the Tumor with Patient Specific Goals to Inform Frontline Selection and Sequencing in Chronic Lymphocytic Leukemia

View More

Bridging Clinical Gaps in Indolent and Aggressive B-Cell Lymphomas: The Investigators Demonstrate How Novel Mechanisms Will Impact Your Practice Tomorrow

View More

Oncology Town Hall™: Primary Investigators Present Key Abstracts in the Management of CLL

View More

Oncology Town Hall™: Primary Investigators Present Key Abstracts in Genitourinary Malignancies from Paris

View More

Show Me Your Care Plan™: Monitoring and Managing Patients With EGFR Exon20 Insertion+ NSCLC

View More

Medical Crossfire®: Clinical Decision-Making Under New Paradigms for HR+/HER2- Breast Cancer

View More

Follicular Lymphoma Workshop: Forging Patient-Centric Plans with Targeted Therapies Across Lines of Care

View More

Advances In™ Desmoid Tumors: Recognizing Disease Burden, Pathophysiology, and Targeted Treatments in Development

View More

Evolving Evidence in Pediatric Brain Cancer: Spotlight on MAPK Inhibitors

View More

State-of-the-Art CMV Care: Experts’ Perspectives on Primary/Secondary Prevention and Management of Refractory/Resistant Infections

View More

Advances In™: Meeting Unmet Clinical Needs in TNBC and HR+ Breast Cancer with TROP2-Targeted Regimens

View More

Addressing Clinical Gaps in Thyroid Cancer Management: Taking Action with Precision Methods to Personalize Treatment Decision-Making

View More

Cancer Summaries and Commentaries™: Report from New Orleans on the Latest Updates in the Treatment of MPNs

View More

Oncology Consultations®: Clinical Impact of HER2-Low Expressing Breast Cancer and Novel Targeted Therapies to Address Unmet Needs in Care

View More

Medical Crossfire®: Antibody-Drug Conjugates Coming to Your Oncology Practice Tomorrow

View More

Medical Crossfire®: What Strategies Can the Care Team Implement to Optimize the Management of Pediatric Patients with NF1?

View More

Oncology Consultations®: Leveraging Clinical Data and Trials to Inform Treatment for Patients with PV

View More

Medical Crossfire®: How Do We Apply the Latest Evidence on Novel Therapies to Prevent and Treat GVHD?

View More

How The Experts Treat Acute Lymphoblastic Leukemia: Case Discussions from Adolescent to Adult

View More

MRD Assessment as a Cornerstone to Clinical Decision-Making in Hematologic Malignancies: Techniques, Utilization, and Best Practices to Optimize Patient Outcomes

View More

How We Do It: Application of State-of-the-Art MF and PV Care Today… With An Eye Toward How New Evidence and Combinations Will be Leveraged Tomorrow

View More

More News

© 2023 MJH Life Sciences

All rights reserved.